Tenet Healthcare Corp (NYSE:THC) – Stock analysts at SunTrust Banks decreased their Q2 2020 EPS estimates for shares of Tenet Healthcare in a report released on Monday, July 6th. SunTrust Banks analyst D. Macdonald now anticipates that the company will earn ($0.59) per share for the quarter, down from their prior forecast of ($0.45). SunTrust Banks has a “Hold” rating and a $25.00 price target on the stock. SunTrust Banks also issued estimates for Tenet Healthcare’s Q3 2020 earnings at $0.07 EPS.

A number of other equities analysts also recently commented on the stock. Barclays upped their target price on shares of Tenet Healthcare from $19.00 to $22.00 and gave the stock an “equal weight” rating in a research note on Monday, May 11th. UBS Group reduced their price objective on Tenet Healthcare from $32.00 to $30.00 and set a “buy” rating on the stock in a report on Thursday, June 11th. Mizuho dropped their price target on Tenet Healthcare from $32.00 to $30.00 and set a “buy” rating on the stock in a research report on Friday, May 29th. Royal Bank of Canada restated a “buy” rating and issued a $26.00 price objective on shares of Tenet Healthcare in a report on Monday, April 13th. Finally, Deutsche Bank dropped their target price on shares of Tenet Healthcare from $31.00 to $25.00 and set a “hold” rating on the stock in a report on Wednesday, May 6th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have issued a buy rating to the stock. Tenet Healthcare has a consensus rating of “Hold” and a consensus price target of $27.42.

THC stock opened at $17.78 on Thursday. Tenet Healthcare has a 12 month low of $10.00 and a 12 month high of $39.37. The firm’s 50-day moving average is $20.82 and its 200 day moving average is $24.97. The company has a market capitalization of $1.86 billion, a PE ratio of -15.07, a P/E/G ratio of 8.78 and a beta of 2.33. The company has a debt-to-equity ratio of 29.98, a current ratio of 1.32 and a quick ratio of 1.24.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Monday, May 4th. The company reported $1.28 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.32 by $0.96. Tenet Healthcare had a positive return on equity of 65.69% and a negative net margin of 0.65%. The company had revenue of $4.52 billion for the quarter, compared to the consensus estimate of $4.63 billion. During the same quarter in the prior year, the company posted $0.54 EPS. Tenet Healthcare’s quarterly revenue was down .6% on a year-over-year basis.

A number of hedge funds have recently made changes to their positions in the stock. Stonebridge Capital Advisors LLC purchased a new stake in Tenet Healthcare in the first quarter valued at about $46,000. Advisor Group Holdings Inc. acquired a new position in shares of Tenet Healthcare during the first quarter valued at about $57,000. Nisa Investment Advisors LLC raised its position in shares of Tenet Healthcare by 256.0% in the 1st quarter. Nisa Investment Advisors LLC now owns 4,450 shares of the company’s stock valued at $64,000 after purchasing an additional 3,200 shares during the last quarter. Amundi Pioneer Asset Management Inc. purchased a new position in shares of Tenet Healthcare in the 4th quarter valued at approximately $111,000. Finally, Aigen Investment Management LP acquired a new stake in Tenet Healthcare in the 1st quarter worth approximately $121,000. Hedge funds and other institutional investors own 99.59% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Further Reading: NASDAQ

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.